Literature DB >> 11326548

Caffeine as a model drug of dependence: recent developments in understanding caffeine withdrawal, the caffeine dependence syndrome, and caffeine negative reinforcement.

R R Griffiths1, A L Chausmer.   

Abstract

Caffeine is an excellent model compound for understanding drugs of abuse/dependence. The results of self-administration and choice studies in humans clearly demonstrate the reinforcing effects of low and moderate doses of caffeine. Caffeine reinforcement has been demonstrated in about 45% of normal subjects with histories of moderate and heavy caffeine use. Recent studies provide compelling evidence that caffeine physical dependence potentiates the reinforcing effects of caffeine through the mechanism of withdrawal symptom avoidance. Tolerance to the subjective and sleep-disrupting effects of caffeine in humans has been demonstrated. Physical dependence as reflected in a withdrawal syndrome in humans has been repeatedly demonstrated in adults and recently demonstrated in children. Withdrawal severity is an increasing function of caffeine maintenance dose, with withdrawal occurring at doses as low as 100 mg per day. Increased cerebral blood flow may be the physiological mechanism for caffeine withdrawal headache. Case studies in adults and adolescents clearly demonstrate that some individuals meet DSM-IV diagnostic criteria for a substance dependence syndrome on caffeine, including feeling compelled to continue caffeine use despite desires and recommendations to the contrary. Survey data suggest that 9% to 30% percent of caffeine consumers may be caffeine dependent according to DSM-IV criteria.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11326548

Source DB:  PubMed          Journal:  Nihon Shinkei Seishin Yakurigaku Zasshi        ISSN: 1340-2544


  12 in total

1.  Sociodemographic correlates of energy drink consumption with and without alcohol: results of a community survey.

Authors:  Lisa K Berger; Michael Fendrich; Han-Yang Chen; Amelia M Arria; Ron A Cisler
Journal:  Addict Behav       Date:  2010-12-28       Impact factor: 3.913

2.  Caffeine stimulation of cortisol secretion across the waking hours in relation to caffeine intake levels.

Authors:  William R Lovallo; Thomas L Whitsett; Mustafa al'Absi; Bong Hee Sung; Andrea S Vincent; Michael F Wilson
Journal:  Psychosom Med       Date:  2005 Sep-Oct       Impact factor: 4.312

3.  Effect of Caffeinated Soft Drinks on Salivary Flow.

Authors:  Gary H Hildebrandt; Daranee Tantbirojn; David G Augustson; Hongfei Guo
Journal:  J Caffeine Res       Date:  2013-09

Review 4.  Intracranial self-stimulation to evaluate abuse potential of drugs.

Authors:  S Stevens Negus; Laurence L Miller
Journal:  Pharmacol Rev       Date:  2014-07       Impact factor: 25.468

5.  Chronic voluntary caffeine intake in male Wistar rats reveals individual differences in addiction-like behavior.

Authors:  Christine H Lee; Olivier George; Adam Kimbrough
Journal:  Pharmacol Biochem Behav       Date:  2020-02-24       Impact factor: 3.533

6.  Acute caffeine treatment increases extracellular nucleotide hydrolysis from rat striatal and hippocampal synaptosomes.

Authors:  Rosane Souza da Silva; Alessandra Nejar Bruno; Ana Maria Oliveira Battastini; João José Freitas Sarkis; Diogo Rizzato Lara; Carla Denise Bonan
Journal:  Neurochem Res       Date:  2003-08       Impact factor: 3.996

Review 7.  Caffeine and headaches.

Authors:  Robert E Shapiro
Journal:  Curr Pain Headache Rep       Date:  2008-08

8.  Caffeine increases the motivation to obtain non-drug reinforcers in rats.

Authors:  A Brianna Sheppard; Skyler C Gross; Sarah A Pavelka; Melanie J Hall; Matthew I Palmatier
Journal:  Drug Alcohol Depend       Date:  2012-02-13       Impact factor: 4.492

9.  Alcohol, nicotine, caffeine, and mental disorders.

Authors:  Marc-Antoine Crocq
Journal:  Dialogues Clin Neurosci       Date:  2003-06       Impact factor: 5.986

10.  Caffeine increases sugar-sweetened beverage consumption in a free-living population: a randomised controlled trial.

Authors:  Russell S J Keast; Boyd A Swinburn; Dhoungsiri Sayompark; Susie Whitelock; Lynn J Riddell
Journal:  Br J Nutr       Date:  2015-01-08       Impact factor: 3.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.